Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0827
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis ; day:17 ; month:2 ; year:2018 ; pages:1-11
Calcified tissue international ; (17.2.2018), 1-11
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Marino, Silvia
- Beteiligte Personen und Organisationen
-
Bishop, Ryan T.
Mollat, Patrick
Idris, Aymen I.
SpringerLink (Online service)
- DOI
-
10.1007/s00223-018-0406-4
- URN
-
urn:nbn:de:1111-2018040829583
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Marino, Silvia
- Bishop, Ryan T.
- Mollat, Patrick
- Idris, Aymen I.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma
Pharmacological inhibition of mTORC2 reduces migration and metastasis in melanoma
Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling
Pharmacological inhibition of Factor XIIa attenuates abdominal aortic aneurysm, reduces atherosclerosis, and stabilizes atherosclerotic plaques
Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle
Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke
Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo
Inhibition of TNF-α restores muscle force, inhibits inflammation, and reduces apoptosis of traumatized skeletal muscles
Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity
Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
Cellular pharmacological inhibition of enveloped virus entry
Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage
Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma
Pharmacological inhibition of mTORC2 reduces migration and metastasis in melanoma
Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling
Pharmacological inhibition of Factor XIIa attenuates abdominal aortic aneurysm, reduces atherosclerosis, and stabilizes atherosclerotic plaques
Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle
Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke
Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo
Inhibition of TNF-α restores muscle force, inhibits inflammation, and reduces apoptosis of traumatized skeletal muscles
Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity
Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
Cellular pharmacological inhibition of enveloped virus entry
Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage
Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma
Pharmacological inhibition of mTORC2 reduces migration and metastasis in melanoma
Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling
Pharmacological inhibition of Factor XIIa attenuates abdominal aortic aneurysm, reduces atherosclerosis, and stabilizes atherosclerotic plaques
Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle
Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke
Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo
Inhibition of TNF-α restores muscle force, inhibits inflammation, and reduces apoptosis of traumatized skeletal muscles
Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity
Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
Cellular pharmacological inhibition of enveloped virus entry